Amgen is refusing U.S. regulators’ request to withdraw an inflammatory disease drug. Elsewhere, Pfizer battled skepticism on ...
Thank you, Tyler. Revenue growth and adjusted operating margin again outpaced our expectations. By segment, financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results